Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(902)
•••
Post by CommonCentsforDollarson Feb 19, 2021 11:53am
211 Views
Post# 32610041

See the trend ?

See the trend ?Canadian cannabis retail sales, seasonally adjusted.

$147.9M - Dec 2019
$154.1M - Jan 2020
$151.9M - Feb 2020
$181.2M - Mar 2020
$178.4M - Apr 2020
$186.4M - May 2020
$201.1M - June 2020
$232.7M - July 2020
$251.7M - Aug 2020
$257.0M - Sept 2020
$270.0M - Oct 2020
$261.0M - Nov 2020
$298.4M - Dec 2020

https://twitter.com/itsdgc/status/1362760887824756738


With retail stores rolling out and coverage / convenience growing.. retail sales keep increasing.


eom
momo
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities